Free Trial
ASX:NAN

Nanosonics (NAN) Stock Price, News & Analysis

Nanosonics logo

About Nanosonics Stock (ASX:NAN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
740,249 shs
Average Volume
N/A
Market Capitalization
A$1.02 billion
P/E Ratio
78.25
Dividend Yield
8.00%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanosonics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NAN Stock News Headlines

Lisa McIntyre to leave Nanosonics board
2013 Bitcoin miner reveals his trading system (free)
While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematically extracting profits from the $4 billion that changes hands in crypto every single day.tc pixel
UBS Group AG Acquires Substantial Stake in Nanosonics Limited
This healthcare stock could deliver a 40% return
See More Headlines

NAN Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Nanosonics investors own include Nanosonics (NNCSF), Calix (CXL), Insignia Financial (IFL), Bubs Australia (BUB), EML Payments (EML), Isracann Biosciences (ISCNF) and Boundless Bio (BOLD).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Financial Services
Current Symbol
ASX:NAN
CIK
N/A
Fax
N/A
Employees
482
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.04
Trailing P/E Ratio
78.25
Forward P/E Ratio
N/A
P/E Growth
2.74
Net Income
A$12.97 million
Net Margins
7.58%
Pretax Margin
N/A
Return on Equity
7.25%
Return on Assets
2.34%

Debt

Debt-to-Equity Ratio
5.11
Current Ratio
6.16
Quick Ratio
4.22

Sales & Book Value

Annual Sales
A$170.01 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
25.90
Book Value
A$0.60 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
303,370,000
Free Float
N/A
Market Cap
A$1.02 billion
Optionable
Not Optionable
Beta
1.55
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (ASX:NAN) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners